Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Hollis-Eden Pharmaceuticals (HEPH)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for HEPH as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
0
AVG
EBITDA
►
-17.7M
AVG
Net Income
►
-17.9M
AVG
Revenue Growth
►
-100%
AVG
Operating Margin
►
-3376.7%
AVG
Net Margin
►
-3377.2%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.143
AVG
Current Ratio
►
7.72
AVG
Quick Ratio
►
7.72
AVG
Book Value Per Share
►
0.396
Cash Per Share
►
0.422
Loading...
STOCK SUMMARY
Open
0.50
Day Range
0.50
-
0.52
52 Week Range
0.27
-
0.98
Volume
34K
Avg Volume (3 mo)
244K
Shares Outstanding
30.5M
Market Cap
15.2M
VALUATION
Price to Earnings (P/E)
►
-0.786
Price to Book (P/B)
►
1.24
AVG
Price to Sales (P/S)
►
0
Return on Assets (ROA)
►
-83.1%
AVG
Return on Equity (ROE)
►
-92.4%
AVG
EV/EBITDA
►
-1.48
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0%
Held by insiders
8.1%
Held by institutions
3.2%
No Sales Breakout Data.